The Effect of Palliative Care Training on Symptom Management and Quality of Life in Chronic Heart Failure
1 other identifier
interventional
84
1 country
2
Brief Summary
Palliative care is of great importance because of poor quality of life and high mortality risk in advanced heart failure. This study was planned as a randomized controlled trial to determine the effect of palliative care training on symptom management, rehospitalization, and quality of life among patients with heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Jan 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2018
CompletedFirst Submitted
Initial submission to the registry
March 4, 2022
CompletedFirst Posted
Study publicly available on registry
March 17, 2022
CompletedMarch 17, 2022
March 1, 2022
12 months
March 4, 2022
March 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Edmonton symptom assessment scale
ESAS consists of 10 symptoms as tiredness, pain, feeling of well-being, nausea, depression, anxiety, lack of appetite, drowsiness, shortness of breath, and others. Each symptom is scored between 0 and 10. While Zero points indicate no symptoms, 10 points are severe of symptoms.
six months
Secondary Outcomes (1)
LVD-36-left ventricular dysfunction questionnaire
six months
Study Arms (2)
palliative care education
EXPERIMENTALThe patients in the intervention group were presented palliative care training in addition to their usual care. The training period lasts at least 45 minutes. After the training, patients were given the book 'Palliative Care in Heart Failure'. In this training, patients were informed about heart failure and pharmacological and non-pharmacological methods for symptoms such as dyspnea, pain, constipation, depression, edema, tiredness, nausea. The patients were followed up by telephone at the first, third, and sixth months after discharge. The patient's symptoms and quality of life were re-evaluated in telephone follow-up. During the follow-up period, the patient's training related to symptoms was repeated. The patients were referred to the physician for the symptoms and problems which they experienced in the house.
usual care
NO INTERVENTIONFirstly, the usual care provided to patients was described. It was determined that patients were not given regular and comprehensive training on heart failure, and no training was given on palliative care. Written educational material was not given to the patients. Patients were not followed up after discharge. Palliative care was not discussed with patients and their relatives. Also, they were not asked about their preferences. In usual care, Heart failure patients received medical treatment for their symptoms during hospitalization.
Interventions
The patients in the intervention group were presented palliative care training in addition to their usual care
Eligibility Criteria
You may qualify if:
- year-old or over,
- Class III and IV heart failure patients according to New York Heart Association (NYHA) classification,
- Patients without any communication problem to prevent participation in the research \[loss of hearing, visual impairment, lack of understanding/speaking in Turkish\], can be contacted by telephone, are literate.
- The patients who were diagnosed with heart failure at least six months ago accepted to participate voluntarily were also included in the study.
You may not qualify if:
- Patients who wish to quit their study voluntarily during the study period and patients who died or worsened during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Marmara U.
Istanbul, Turkey (Türkiye)
Marmara University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gülşah Çamcı, PhD
Marmara University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The patients were distributed with the minimization method of covariate-oriented randomization. According to NYHA (class III, IV), sex (male and female), and the number of hospitalizations (≤3 and ≥4) within one year, the patients were randomly appointed to the control and intervention groups. Thus, the patients in the intervention and control groups were distributed as homogeneous.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Prof
Study Record Dates
First Submitted
March 4, 2022
First Posted
March 17, 2022
Study Start
January 1, 2017
Primary Completion
December 31, 2017
Study Completion
November 10, 2018
Last Updated
March 17, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
After the article is published, the results of the study will be shared.